Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Laparoscopic retroperitoneal lymph node dissection.

G Janetschek1

  • 1Department of Urology, University of Innsbruck, Innsbruck, Austria. guenter.janetschek@elisabethinen.or.at

The Urologic Clinics of North America
|March 30, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

28-Year Survival following Several Metastasectomies, Going through 8th Line Systemic Therapy in a Case of mRCC.

Case reports in urology·2015
Same author

Laparoscopic adenomectomy versus Eraser laser enucleation of the prostate.

World journal of urology·2015
Same author

Tissue effects resulting from eraser laser enucleation of the prostate: in vivo investigation.

Urologia internationalis·2013
Same author

The use of mannitol in partial and live donor nephrectomy: an international survey.

World journal of urology·2012
Same author

[Partial nephrectomy - pro laparoscopy].

Der Urologe. Ausg. A·2012
Same author

[Retroperitoneal lymphadenectomy - pro laparoscopy].

Der Urologe. Ausg. A·2012
Same journal

An Unprecedented Era of Innovation in Non-Muscle-Invasive Bladder Cancer.

The Urologic clinics of North America·2026
Same journal

Hubert Humphrey's Bladder Cancer: If He Could Have Time Traveled, Would that Have Changed the Outcome?

The Urologic clinics of North America·2026
Same journal

Key Clinical Trials Shaping the Future of Superficial High-Risk Bladder Cancer Management.

The Urologic clinics of North America·2026
Same journal

Future Directions: Artificial Intelligence and Digital Tools in Bladder Cancer Care.

The Urologic clinics of North America·2026
Same journal

Economic Considerations in the Management of Superficial Bladder Cancer.

The Urologic clinics of North America·2026
Same journal

Patient-Centered Approaches to Non-Muscle-Invasive Bladder Cancer Care.

The Urologic clinics of North America·2026
See all related articles

Laparoscopic retroperitoneal lymph node dissection (RPLND) offers better efficiency, lower morbidity, and reduced costs for testicular cancer compared to open surgery. Patient quality of life and diagnostic accuracy are comparable, making it a preferred approach.

Area of Science:

  • Urology
  • Surgical Oncology
  • Minimally Invasive Surgery

Background:

  • Testicular cancer treatment often involves retroperitoneal lymph node dissection (RPLND).
  • Open RPLND is a traditional approach, but minimally invasive techniques are evolving.
  • Patient quality of life and surgical outcomes are key considerations in treatment selection.

Purpose of the Study:

  • To evaluate the efficacy and outcomes of laparoscopic RPLND versus open surgery for clinical stage I testicular tumors.
  • To assess the feasibility and results of laparoscopic RPLND in patients who have undergone chemotherapy.
  • To determine the role of diagnostic laparoscopic RPLND in managing stage IIb testicular cancer.

Main Methods:

  • Comparative analysis of laparoscopic versus open RPLND for clinical stage I testicular tumors.

Related Experiment Videos

  • Quality of life assessment comparing surgical options and chemotherapy.
  • Evaluation of laparoscopic RPLND outcomes in post-chemotherapy and stage IIb testicular cancer patients.

    • Main Results:

    • Laparoscopic RPLND demonstrated superiority in efficiency, morbidity, and cost compared to open surgery.
    • Diagnostic accuracy was equivalent between laparoscopic and open RPLND.
    • Patients preferred laparoscopic surgery over open surgery and chemotherapy.
    • Laparoscopic RPLND is feasible and effective after chemotherapy, yielding results comparable to clinical stage I disease.
    • In stage IIb disease, diagnostic laparoscopic RPLND can help spare chemotherapy cycles or allow for minimally morbid residual tumor removal.

    Conclusions:

    • Laparoscopic RPLND is a superior approach for clinical stage I testicular tumors regarding efficiency, morbidity, and cost.
    • It offers comparable diagnostic accuracy and improved patient quality of life.
    • Laparoscopic RPLND is a viable and effective option for post-chemotherapy management and selected stage IIb cases.
    • The primary challenge for widespread adoption is the steep learning curve and specialized training required.